Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;39(Database issue):D1035-41.
doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

Craig Knox  1 , Vivian Law, Timothy Jewison, Philip Liu, Son Ly, Alex Frolkis, Allison Pon, Kelly Banco, Christine Mak, Vanessa Neveu, Yannick Djoumbou, Roman Eisner, An Chi Guo, David S Wishart
Affiliations

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

Craig Knox et al. Nucleic Acids Res. 2011 Jan.

Abstract

DrugBank (http://www.drugbank.ca) is a richly annotated database of drug and drug target information. It contains extensive data on the nomenclature, ontology, chemistry, structure, function, action, pharmacology, pharmacokinetics, metabolism and pharmaceutical properties of both small molecule and large molecule (biotech) drugs. It also contains comprehensive information on the target diseases, proteins, genes and organisms on which these drugs act. First released in 2006, DrugBank has become widely used by pharmacists, medicinal chemists, pharmaceutical researchers, clinicians, educators and the general public. Since its last update in 2008, DrugBank has been greatly expanded through the addition of new drugs, new targets and the inclusion of more than 40 new data fields per drug entry (a 40% increase in data 'depth'). These data field additions include illustrated drug-action pathways, drug transporter data, drug metabolite data, pharmacogenomic data, adverse drug response data, ADMET data, pharmacokinetic data, computed property data and chemical classification data. DrugBank 3.0 also offers expanded database links, improved search tools for drug-drug and food-drug interaction, new resources for querying and viewing drug pathways and hundreds of new drug entries with detailed patent, pricing and manufacturer data. These additions have been complemented by enhancements to the quality and quantity of existing data, particularly with regard to drug target, drug description and drug action data. DrugBank 3.0 represents the result of 2 years of manual annotation work aimed at making the database much more useful for a wide range of 'omics' (i.e. pharmacogenomic, pharmacoproteomic, pharmacometabolomic and even pharmacoeconomic) applications.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A screenshot montage of some of DrugBank 3.0's new browser views (GenoBrowse, Interax, ClassBrowse, PathBrowse).
See this image and copyright information in PMC

References

    1. Zhu F, Han G, Kumar P, Liu X, Ma X, Wei X, Huang L, Guo Y, Han L, Zheng C, et al. Update of TTD: therapeutic target database. Nucleic Acids Res. 2010;38(Database issue):D787–D791. - PMC - PubMed
    1. Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, Zhu W, Chen K, Wang X, Jiang H. PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics. 2008;9:104. - PMC - PubMed
    1. Kuhn M, Szklarczyk D, Franceschini A, Campillos M, von Mering C, Jensen LJ, Beyer A, Bork P. STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res. 2010;38(Database issue):D552–D556. - PMC - PubMed
    1. Gunther S, Kun M, Dunkel M, Camillos M, Senger C, Petsalaki E, Ahmed J, Urdiales EG, Gewiess A, Jensen LJ, et al. SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res. 2008;36(Database issue):D919–D922. - PMC - PubMed
    1. Russ AP, Lampel S. The druggable genome: an update. Drug Discov. Today. 2005;10:1607–1610. - PubMed

Publication types

Substances